The trajectory of Viagra presents a complex picture for shareholders. While the initial introduction generated significant gains, the expiration of its exclusive rights opened the door to off-brand alternatives, https://bookmarkvids.com/story131559/sildenafil-and-big-pharma-a-volatile-opportunity